LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
1
90.55 27.76 464 6928 0.0670 0.4243
MN20160318_Q01
H08
MCF 10A-H2B-mCherry Neratinib
1
92.25 27.76 197 6873 0.0287 0.2795
MN20160318_Q01
E14
MCF 10A-H2B-mCherry Neratinib
1
92.25 27.76 1024 6873 0.1490 0.5742
MN20160318_Q01
E14
MCF 10A-H2B-mCherry Neratinib
1
92.25 27.76 1 6873 0.0001 -0.3416
MN20160318_Q01
H08
MCF 10A-H2B-mCherry Neratinib
1
92.25 27.76 443 6873 0.0645 0.4167
MN20160318_Q01
H08
MCF 10A-H2B-mCherry Neratinib
1
93.96 27.76 203 6849 0.0296 0.2845
MN20160318_Q01
E14
MCF 10A-H2B-mCherry Neratinib
1
93.96 27.76 1069 6849 0.1561 0.5832
MN20160318_Q01
E14
MCF 10A-H2B-mCherry Neratinib
1
93.96 27.76 1 6849 0.0001 -0.3418
MN20160318_Q01
H08
MCF 10A-H2B-mCherry Neratinib
1
93.96 27.76 436 6849 0.0637 0.4142
MN20160318_Q01
H08
MCF 10A-H2B-mCherry Neratinib
1
95.66 27.76 204 6712 0.0304 0.2865
MN20160318_Q01
E14
MCF 10A-H2B-mCherry Neratinib
1
95.66 27.76 1176 6712 0.1752 0.6051
MN20160318_Q01
E14
MCF 10A-H2B-mCherry Neratinib
1
95.66 27.76 1 6712 0.0001 -0.3428
MN20160318_Q01
H08
MCF 10A-H2B-mCherry Neratinib
1
95.66 27.76 421 6712 0.0627 0.4098
MN20160318_Q01
H08
MCF 10A-H2B-mCherry Neratinib
3.1623
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
1.95 27.76 499 225 2.2164 1.6031
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
1.95 27.76 9 225 0.0400 -0.3113
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
1.95 27.76 696 225 3.0914 1.9063
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
3.66 27.76 525 283 1.8491 1.4022
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
3.66 27.76 8 283 0.0282 -0.3099
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
3.66 27.76 722 283 2.5429 1.6416
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
5.36 27.76 548 320 1.7106 1.3286
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
5.36 27.76 11 320 0.0343 -0.2307
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
5.36 27.76 741 320 2.3130 1.5365
MN20160318_Q01
L09